XPH

This ETF focuses on the pharmaceutical sector, which includes companies that develop and sell medicines. Investors use it to gain exposure to drug makers without picking individual stocks. The industry faces challenges like patent expirations but benefits from innovation in treatments. Performance often depends on drug approvals and healthcare spending trends.